MENU
VRTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Vertex Pharmaceuticals (VRTX) Ownership - Who owns Vertex Pharmaceuticals?
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
50 Northern Avenue
Phone
+1 617 341-6100
Employees
5400
Web
https://www.vrtx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
126.52B
P/E Ratio
32.76
Total Cash
6.12B
Projected Growth
1.37
Total Debt
1.75B
Revenue
11.02B
Risk (Beta)
0.43
Dividend Yield
N/A
Total Cash/Share
23.82
Total Debt/Equity
43.97
Revenue/Share
42.73 USD as % of share price
Fundamentals
VRTX
Capitalization
127B
P/E Ratio
32.76
Risk (Beta)
0.43
Dividend Yield
N/A
Total Cash
6.12B
Total Cash/Share
23.82
Total Debt
1.75B
Total Debt/Equity
43.97
Projected Growth (PEG Ratio)
1.37
Revenue/Share (as % of the share price)
42.73%
Revenue
11B
ROE
N/A
Book Value
16.4B
P/B Ratio
7.59
Cash Flow
N/A
Earnings
-2.08
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2.6M
Current Ratio
2.69
Current Revenue Per Employee
477377.06
Dividends Per Share - Security
N/A
EBITDA
486M
Float
N/A
Float - Current
N/A
Gross Income Margin
85.46
Revenue To Assets
-2.37
Shares Held By Institutions
363B
Shares Outstanding - Current
257M
Total Liabilities
6.12B
Total Volume MTD
N/A
Value
-1
Gain YTD
20.392
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a company that discovers and develops novel, small molecule pharmaceuticals
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
50 Northern Avenue
Phone
+1 617 341-6100
Employees
5400
Web
https://www.vrtx.com